PCOS/PMOS in Teenagers: Why Overdiagnosis Is a Real Risk — And How Diagnosis Should Be Done

Why normal puberty looks exactly like PMOS

This is the crux of the problem. In the first years after menarche, the following are physiologically normal:

Irregular cycles. The hypothalamic-pituitary-ovarian axis takes time to mature. Anovulatory cycles are the norm in the first postmenarchal year and remain common for two to three years. Roughly half of cycles in the first year after menarche are anovulatory.

Multifollicular ovaries. The adolescent ovary normally contains numerous antral follicles. Multifollicular ovarian morphology is a normal developmental finding, not pathology. Studies applying adult ultrasound criteria to healthy adolescents find "polycystic" morphology in a very large proportion of entirely normal girls.

Raised AMH. AMH peaks in the second decade. A high AMH in a teenager reflects normal ovarian reserve, not PMOS.

Acne. Physiological adrenarche produces acne in a majority of adolescents. Acne alone is weak evidence of hyperandrogenism at this age.

Transient insulin resistance. Physiological insulin resistance occurs during puberty and typically resolves. It should not be over-interpreted.

Because every one of these overlaps with the adult criteria, an ultrasound-led approach in a 14-year-old will generate a diagnosis in a large number of girls whose ovaries and cycles will normalise without intervention.

---

The correct adolescent criteria

Criterion 1: Irregular cycles, defined by post-menarchal age

The first row is the one most often ignored. A girl 8 months past menarche with erratic cycles does not have a menstrual disorder; she has a maturing axis.

Criterion 2: Hyperandrogenism

• Hirsutism is the most specific clinical sign. Assess with the modified Ferriman-Gallwey score, applying ethnicity-appropriate thresholds for South Asian girls.
• Severe or persistent inflammatory acne, particularly moderate-to-severe nodulocystic acne, or acne unresponsive to standard topical therapy.
• Biochemical: calculated free testosterone or free androgen index using a reliable assay. Direct free testosterone immunoassays are not adequate. Adolescent reference ranges must be used — adult ranges will misclassify.

What must NOT be used

• Pelvic ultrasound — not a diagnostic criterion until ≥ 8 years post-menarche
• AMH — not recommended in adolescents; specificity is poor
• LH:FSH ratio — not a criterion at any age

---

The "at risk" category — a better answer than a premature label

Many adolescents will have some features but not meet full criteria. The guideline provides for this: these girls should be regarded as "at increased risk" of PMOS, and re-evaluated at or before full reproductive maturity — 8 years post-menarche.

This is clinically important and underused. It allows you to:

• Start lifestyle intervention and metabolic monitoring, which are beneficial regardless of final diagnosis
• Treat the presenting symptom — acne, hirsutism, cycle irregularity — on its own merits
• Avoid attaching a chronic, stigmatising diagnosis with fertility and diabetes implications to a girl whose features may resolve
• Schedule a definite point of reassessment rather than leaving the question open indefinitely

For a distressed adolescent and an anxious parent, "we are going to monitor this carefully and reassess, and here is what we will do meanwhile" is both more honest and more useful than a premature label.

---

What must be excluded in an adolescent

The exclusion list matters more, not less, in this age group:

• Pregnancy — regardless of stated history
• Thyroid dysfunction — TSH
• Hyperprolactinaemia — prolactin
• Non-classic congenital adrenal hyperplasia — morning follicular 17-OHP. Particularly relevant in South Asian populations.
• Eating disorders and functional hypothalamic amenorrhoea — this is the most commonly missed alternative diagnosis in this age group. Low body weight, excessive exercise, restrictive eating and psychosocial stress produce amenorrhoea with a fundamentally different mechanism and management. FSH and LH will typically be low or low-normal rather than raised. Mislabelling functional hypothalamic amenorrhoea as PMOS — and prescribing a contraceptive pill to "regulate" it — masks the problem and delays appropriate care for years.
• Primary ovarian insufficiency — raised FSH
• Androgen-secreting tumour — rapid virilisation, clitoromegaly, voice change

---

Treating the adolescent: what actually helps

Lifestyle intervention is first-line, framed carefully. In adolescents, weight-focused messaging carries real risk of precipitating disordered eating in a group already at elevated risk of body image distress and depression. Frame it around cycle regularity, energy, skin and long-term health rather than weight or appearance. Avoid weighing at every visit where this is likely to be counterproductive.

Combined oral contraceptives can be used for cycle regulation and hyperandrogenic symptoms in adolescents, including in those in the "at risk" category. They do not treat the underlying condition and do not affect future fertility — a fear that causes many Indian families to refuse them. That fear should be addressed explicitly.

Metformin may be considered, particularly where BMI is raised or there is demonstrated impaired glucose tolerance, and may be combined with lifestyle intervention.

Anti-androgens (spironolactone, finasteride, cyproterone) require reliable contraception because of the risk of feminisation of a male fetus. This is a significant practical consideration in adolescent prescribing.

Mental health screening is mandatory, not optional. Anxiety and depression are the most commonly reported co-morbidities in this population, and adolescence is when body-image-related distress from hirsutism, acne and weight change is most severe.

---

For gynaecologists and paediatricians: practice points

Do not order a pelvic ultrasound to diagnose PMOS in a teenager. It cannot establish the diagnosis and its result will bias both you and the family. If a scan is being done for another indication — pelvic pain, suspected structural anomaly — record explicitly that ovarian morphology is not being used diagnostically.

Beware the referral that arrives pre-labelled. A common pathway in Indian practice: a 15-year-old has irregular cycles, a transabdominal scan is done at a diagnostic centre, the report reads "polycystic ovaries", and she arrives already told she has PCOS. Unpicking that is harder than diagnosing correctly at the outset, but it must be done.

Use post-menarchal age, not chronological age, for every cycle-related judgement.

Document the reassessment date. For any girl placed in the "at risk" category, record when she should be re-evaluated — 8 years post-menarche — and communicate it to the family in writing.

Screen for eating disorders before, not after, labelling. A single question about restrictive eating and exercise habits changes management more often than any hormone test in this age group.